Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness.
<h4>Background</h4>Plain pneumococcal polysaccharide (PPS) booster administered during second year of life has been shown to cause hyporesponsiveness. We assessed the effects of PPS booster on splenic memory B cell responses and persistence of PPS-specific long-lived plasma cells in the...
Guardado en:
Autores principales: | Stefania P Bjarnarson, Hreinn Benonisson, Giuseppe Del Giudice, Ingileif Jonsdottir |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f10eeacfa7784a39a74b7409afe35bcd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.
por: Daniel R Feikin, et al.
Publicado: (2013) -
Pneumococcal conjugate vaccines: New hope for infancy
por: Black,Steven B., et al.
Publicado: (2001) -
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.
por: C Raina Macintyre, et al.
Publicado: (2014) -
Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines.
por: Thomas Benfield, et al.
Publicado: (2013) -
Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Lucía Fernández-Delgado, et al.
Publicado: (2021)